Skip to content
Clinical Trials – home

Michał Bogacki – DOBROSTAN

Verifiedinfo

Poland ul. Ślężna 27, 53-301 Wroclaw, Poland

  • 1 trial recruiting
  • Asthma · Chronic obstructive pulmonary disease · Seasonal allergy
  • Adults and children

About Specializations

Michał Bogacki – DOBROSTAN in Wroclaw, Poland specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Seasonal allergy, Conjunctivitis allergic, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The research site concentrates on clinical studies of mild to moderate asthma, seeking to advance therapeutic options for this common respiratory condition.

  • Evaluation of therapeutic equivalence between inhaler formulations
  • Measurement of lung function using forced expiratory volume in 1 second (FEV1) endpoints
  • Assessment of safety and efficacy in adult asthma patients

Ongoing work at Michał Bogacki – DOBROSTAN aims to improve treatment options for people with asthma by confirming that new inhaler technologies perform as well as established products.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Ślężna 2753-301 WroclawPoland
Recruiting now
1 trial
Conditions studied
5
Partner status
Verified

More sites in WroclawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

14 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Seasonal allergy

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Placebo
  • Sponsor:Probelte Pharma S.L.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Seasonal allergy

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Probelte Pharma S.L.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Asthma

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:6-THIO-ALFA-D-GLUCOPYRANOSYL 6-THIO-ALFA-D-GLUCOPYRANOSIDE
  • Sponsor:Aer Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.